abrdn Life Sciences Investors (HQL) Competitors $13.16 0.00 (0.00%) As of 10:39 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HQL vs. CET, GSBD, MFIC, NMFC, PFLT, BCSF, BBDC, AWF, HQH, and PHKShould you be buying abrdn Life Sciences Investors stock or one of its competitors? The main competitors of abrdn Life Sciences Investors include Central Securities (CET), Goldman Sachs BDC (GSBD), MidCap Financial Investment (MFIC), New Mountain Finance (NMFC), PennantPark Floating Rate Capital (PFLT), Bain Capital Specialty Finance (BCSF), BARINGS BDC (BBDC), AllianceBernstein Global High Income Fund (AWF), abrdn Healthcare Investors (HQH), and PIMCO High Income Fund (PHK). These companies are all part of the "financial services" industry. abrdn Life Sciences Investors vs. Its Competitors Central Securities Goldman Sachs BDC MidCap Financial Investment New Mountain Finance PennantPark Floating Rate Capital Bain Capital Specialty Finance BARINGS BDC AllianceBernstein Global High Income Fund abrdn Healthcare Investors PIMCO High Income Fund Central Securities (NYSE:CET) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations. Is CET or HQL a better dividend stock? Central Securities pays an annual dividend of $2.30 per share and has a dividend yield of 4.8%. abrdn Life Sciences Investors pays an annual dividend of $1.89 per share and has a dividend yield of 14.4%. Do insiders and institutionals hold more shares of CET or HQL? 8.7% of Central Securities shares are held by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are held by institutional investors. 9.5% of Central Securities shares are held by company insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, CET or HQL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentral Securities$296.20M4.69N/AN/AN/Aabrdn Life Sciences InvestorsN/AN/AN/AN/AN/A Does the media refer more to CET or HQL? In the previous week, abrdn Life Sciences Investors had 1 more articles in the media than Central Securities. MarketBeat recorded 1 mentions for abrdn Life Sciences Investors and 0 mentions for Central Securities. Central Securities' average media sentiment score of 0.00 equaled abrdn Life Sciences Investors'average media sentiment score. Company Overall Sentiment Central Securities Neutral abrdn Life Sciences Investors Neutral Which has more risk & volatility, CET or HQL? Central Securities has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, abrdn Life Sciences Investors has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Is CET or HQL more profitable? Company Net Margins Return on Equity Return on Assets Central SecuritiesN/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A Summaryabrdn Life Sciences Investors beats Central Securities on 4 of the 6 factors compared between the two stocks. Get abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HQL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HQL vs. The Competition Export to ExcelMetricabrdn Life Sciences InvestorsFIN IndustryFinance SectorNYSE ExchangeMarket Cap$380.33M$3.79B$12.10B$20.83BDividend Yield14.48%6.64%5.57%3.69%P/E RatioN/AN/A19.2327.67Price / SalesN/A22.6826.2659.34Price / CashN/A18.7221.5022.13Price / BookN/A1.212.344.67Net IncomeN/A$158.51M$997.60M$994.58M7 Day Performance0.46%-0.59%0.77%0.26%1 Month Performance4.40%1.71%4.75%5.55%1 Year Performance-12.67%0.72%542.23%11.06% abrdn Life Sciences Investors Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HQLabrdn Life Sciences InvestorsN/A$13.16flatN/A-14.3%$380.33MN/A0.00N/ACETCentral SecuritiesN/A$47.94-0.7%N/A+7.6%$1.39B$296.20M0.006GSBDGoldman Sachs BDC0.9166 of 5 stars$11.53-0.1%$12.00+4.1%-22.1%$1.35B$434.37M25.62N/APositive NewsMFICMidCap Financial Investment2.178 of 5 stars$12.69-0.2%$14.00+10.3%-13.9%$1.19B$113.46M10.23N/APositive NewsNMFCNew Mountain Finance2.0024 of 5 stars$10.57-1.2%$10.67+0.9%-13.0%$1.15B$371.67M10.57N/APositive NewsPFLTPennantPark Floating Rate Capital3.7861 of 5 stars$10.47-0.8%$10.92+4.3%-7.6%$1.05B$84.09M7.48658Ex-DividendAnalyst ForecastBCSFBain Capital Specialty Finance1.8426 of 5 stars$15.02-1.5%$16.50+9.9%-5.4%$989.24M$292.65M8.631,000High Trading VolumeBBDCBARINGS BDC3.111 of 5 stars$9.23-0.5%$9.67+4.7%-4.8%$978.20M$286.17M9.8226Positive NewsAWFAllianceBernstein Global High Income FundN/A$11.05-0.5%N/A+5.5%$957.15MN/A0.00N/APositive NewsHQHabrdn Healthcare InvestorsN/A$15.59-1.5%N/A-15.5%$852.64MN/A0.00147,000Positive NewsPHKPIMCO High Income FundN/A$4.82-0.2%N/A+0.0%$828.30MN/A0.00147,000 Related Companies and Tools Related Companies CET Competitors GSBD Competitors MFIC Competitors NMFC Competitors PFLT Competitors BCSF Competitors BBDC Competitors AWF Competitors HQH Competitors PHK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HQL) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HQL Stock Alerts